Numab Therapeutics is Drug Discovery in Switzerland that focus on multispecific antibody business. Founded in 2011. They cover business area such as operator, multispecific antibody-base immunotherapy, multispecific biotherapeutic, mono- or multispecific antibody fragment-base therapeutic, tailor pharmacokinetic property, healthcare industry, their platform, multiple target, chronic inflammation, cancer.
2011
( 13 years old in 2024 )
Multispecific Antibody
-
Einsiedlerstrasse 34
8820 Wädenswil
Switzerland
Private
operatormultispecific antibody-base immunotherapymultispecific biotherapeuticmono- or multispecific antibody fragment-base therapeutictailor pharmacokinetic propertyhealthcare industrytheir platformmultiple targetchronic inflammationcancer
* We use standard office opening hours in near Numab Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Numab Therapeutics is Drug Discovery business from Switzerland that founded in 2011 (13 years old in 2024), Numab Therapeutics business is focusing on Multispecific Antibody.
Numab Therapeutics headquarter office and corporate office address is located in Einsiedlerstrasse 34 8820 Wädenswil Switzerland.
Numab Therapeutics was founded in Switzerland.
In 2024, Numab Therapeutics is currently focus on multispecific antibody sector.
Above is snippet of Google Trends for "multispecific antibody" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Numab Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
